MARTINI, Petra
 Distribuzione geografica
Continente #
NA - Nord America 5.692
AS - Asia 3.601
EU - Europa 2.943
SA - Sud America 652
AF - Africa 89
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.000
Nazione #
US - Stati Uniti d'America 5.484
SG - Singapore 1.521
IT - Italia 951
CN - Cina 936
PL - Polonia 629
BR - Brasile 535
HK - Hong Kong 370
DE - Germania 354
GB - Regno Unito 282
VN - Vietnam 227
FI - Finlandia 126
ID - Indonesia 108
CA - Canada 102
RU - Federazione Russa 98
UA - Ucraina 92
IN - India 85
TR - Turchia 85
MX - Messico 84
SE - Svezia 76
NL - Olanda 62
FR - Francia 57
JP - Giappone 50
AT - Austria 41
ZA - Sudafrica 41
AR - Argentina 40
TW - Taiwan 39
BD - Bangladesh 34
ES - Italia 34
BE - Belgio 32
CH - Svizzera 30
PK - Pakistan 29
AU - Australia 20
CZ - Repubblica Ceca 16
EC - Ecuador 16
IQ - Iraq 15
KR - Corea 15
LT - Lituania 15
BG - Bulgaria 13
ET - Etiopia 13
UZ - Uzbekistan 13
IR - Iran 12
CL - Cile 11
CO - Colombia 10
HU - Ungheria 9
PE - Perù 8
PH - Filippine 8
PY - Paraguay 8
BO - Bolivia 7
IL - Israele 7
MA - Marocco 7
VE - Venezuela 7
EG - Egitto 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
GY - Guiana 5
BW - Botswana 4
JO - Giordania 4
RO - Romania 4
SA - Arabia Saudita 4
TN - Tunisia 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
IE - Irlanda 3
KE - Kenya 3
LB - Libano 3
NP - Nepal 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GA - Gabon 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
MU - Mauritius 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
Totale 12.990
Città #
Singapore 860
Ashburn 680
Warsaw 620
Hong Kong 358
Beijing 356
Santa Clara 345
Fairfield 339
Ann Arbor 278
Chandler 270
Woodbridge 238
Ferrara 214
Houston 186
Los Angeles 155
Munich 136
Seattle 134
New York 131
Dallas 130
Wilmington 125
The Dalles 122
Cambridge 107
Addison 90
Jacksonville 90
Milan 90
Jakarta 83
Princeton 73
Buffalo 70
Nanjing 69
Dong Ket 67
São Paulo 63
Shanghai 60
Ho Chi Minh City 58
Nuremberg 55
London 54
Turku 54
Boardman 47
Izmir 47
Mexico City 46
Helsinki 44
Redwood City 43
Rome 43
San Diego 41
Bologna 39
Dearborn 38
Brooklyn 37
Hanoi 34
Tokyo 34
Chicago 32
Montreal 32
Brussels 30
Hsinchu 30
Boston 27
Orem 27
Toronto 25
Bremen 24
Poplar 24
Phoenix 23
Chennai 22
Denver 22
Hefei 22
Vienna 22
Padova 21
Atlanta 20
Moscow 20
Chengdu 19
Amsterdam 17
Mumbai 17
San Francisco 17
Frankfurt am Main 16
Tianjin 16
Zurich 16
L’Aquila 15
Nanchang 15
Rio de Janeiro 15
Stockholm 15
Charlotte 14
Johannesburg 14
Wuhan 14
Ankara 13
Florence 13
Legnaro 13
Tashkent 13
Addis Ababa 12
Brasília 12
Brno 12
Council Bluffs 12
Monmouth Junction 12
Ottawa 12
Querétaro 12
Belo Horizonte 11
Da Nang 11
Falls Church 11
Guangzhou 11
Shenyang 11
Washington 11
Ferrara di Monte Baldo 10
Karachi 10
Kunming 10
Lappeenranta 10
San Jose 10
Treviso 10
Totale 8.158
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 465
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 351
High-Yield Cyclotron Production of Metallic Radioisotopes for Nuclear Medicine 329
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 291
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 277
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 274
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 250
LARAMED: A Laboratory for Radioisotopes of Medical Interest 239
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 238
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 236
A solvent-extraction module for cyclotron production of high-purity technetium-99m 223
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 211
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 203
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 203
Radiofarmaci marcati con altri radionuclidi (Indio-111, Rame-64, Iodio-124, Zirconio-89) 192
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 189
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 181
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 179
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 174
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 170
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 169
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 165
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 165
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 163
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 160
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 158
Extraction techniques of 99mTc from 100Mo Metal Target 157
A late Neanderthal tooth from northeastern Italy 156
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 151
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 147
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 145
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 143
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 139
Technetium complexes and radiopharmaceuticals with scorpionate ligands 137
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 129
67Cu Production Capabilities: A Mini Review 123
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 119
Advances in the automation technologies within LARAMED project 116
Production of 47Sc with natural vanadium targets: results of the PASTA project 115
Perspectives on the use of liquid extraction for radioisotope purification 111
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging 111
Recovery of Molybdenum Precursor Material in the Cyclotron-Based Technetium-99m Production Cycle 111
null 109
LARAMED: a LAboratoty of RAdioisotopes for MEDicine 109
Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent 107
PASTA Project: Data Analysis 104
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 104
Cyclotron-Production of 51/52Mn Isotopes: the METRICS Project Final Report 102
null 102
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 98
A method and a target for the production of 67Cu 96
First in vivo imaging studies of cyclotron produced 99mTc-HMPAO 95
PASTA project: optimization of a radiochemical separation of Sc from Ti 95
Cyclotron-Production of Mn-52: an update on the METRICS project 93
Cyclotron-based production of the theranostic radionuclides 67Cu and 47Sc 91
A method and a target to produce 67Cu 91
Recent Advances in Preclinical Studies of the Theranostic Agent [64Cu]CuCl2 90
Production of 67Cu by enriched 70Zn targets: First measurements of formation cross sections of 67Cu, 64Cu, 67Ga, 66Ga, 69mZn and 65Zn in interactions of 70Zn with protons above 45 MeV 90
Synthetic and nanotechnological approaches for a diagnostic use of manganese 90
[89Zr]ZrTrastuzumab automatic preparation on commercial cassette base synthesis module 89
Manganese-Loaded Liposomes: An In Vitro Study for Possible Diagnostic Application 89
METRICS project: Synthesis of Manganese Complexes as potential PET/MRI Agents 88
LARAMED Facility Status Report 88
Development of Efficient Separation Procedures of Cyclotron Produced Manganese-52 for the METRICS Project 87
In vivo evaluation of nanostructured lipid labelled with 99mTc 86
New developments on the extraction and separation of cyclotron-produced Tc-99m from molybdenum metal target 86
Development of a new class of Mn(II) complexes for MRI applications 85
A universal cassette-based system for the dissolution of solid targets 85
TECHN-OSP: Molybdenum target preparation techniques for cyclotron-based technetium-99m production 84
Development and automation of radiochemical processes for medical radioisotopes. 84
Copper isotopes production test with medical cyclotron: preliminary irradiation on natZn and Cu/Zn separation. 84
Manganese complexes for multimodal PET/MRI imaging: progress of METRICS project 83
68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives 82
Feasibility study for the production of 155Tb using different 155Gd2O3 target configurations 81
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 79
Cyclotron production of manganese-52: a promising avenue for multimodal PET/MRI imaging 78
Synthesis and characterization of manganese dithiocarbamate complexes: New evidence of dioxygen activation 78
Cyclotron-production of 52/51Mn isotopes: an update on the METRICS project 78
Results of INTEFF_TOTEM Project: magneTron sputering cyclotron TargEt Manufacturing 78
Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities 77
INTEFF_TOTEM Project: magneTron sputtering cyclOtron TargEt Manufacturing 76
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 76
The Laramed project at LNL: 67Cu and 47Sc production for theranostic applications 75
Cyclotron-production of manganese-52 for multi-modal imaging applications 74
APHRODITE-155_Accelerator-based Production of tHeranostic radionuclides: Investigations on TErbium-155 70
Development of an automatic separation/extraction module for the accelerator 99mTc production from 100Mo enriched molybdenum metal targets 70
Highly efficient micro-scale liquid-liquid in-flow extraction of99mtc from molybdenum 69
[89Zr]ZrTrastuzumab preparation based on commercial cassette base synthesis module 68
Research on Emerging Medical radIonuclides from the X-sections (REMIX): The Accelerator-based Production of 47Sc, 149Tb, 152Tb, 155Tb and 161Tb 67
Production of 67Cu with medical cyclotron: target manufacturing technology development and recovery process optimization 66
High yield separation of Cu-67 from irradiated zinc targets 66
The LARAMED Facility Status 66
Cyclotron-based production of innovative medical radionuclides at the INFN-LNL: state of the art and perspective 65
Production of Copper-61 from natZn(p,a)61Cu reaction route by solid target irradiation: preliminary results 63
Cyclotron production of 52Mn-radiopharmaceuticals and on phantom PET-imaging 60
null 60
Design of a Universal Dissolution System for Solid Cyclotron Targets 60
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer 59
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study. 58
LARAMED Facility status report at LNL 58
Totale 12.706
Categoria #
all - tutte 66.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.103
Totale 74.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021854 0 0 0 0 0 94 97 193 77 194 102 97
2021/2022829 31 44 39 33 33 31 72 58 52 56 139 241
2022/2023758 94 103 33 89 91 63 69 42 64 21 59 30
2023/2024818 34 56 70 37 58 111 72 47 30 43 43 217
2024/20253.573 110 81 266 168 334 237 144 200 547 413 730 343
2025/20264.136 809 278 662 934 1.292 161 0 0 0 0 0 0
Totale 13.282